c-Myc regulates proliferation and Fgf10 expression in airway smooth muscle after airway epithelial injury in mouse by Volckaert, Thomas et al.
c-Myc Regulates Proliferation and Fgf10 Expression in
Airway Smooth Muscle after Airway Epithelial Injury in
Mouse
Thomas Volckaert1,2,3, Alice Campbell1, Stijn De Langhe1,4*
1Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, Colorado, United States of America, 2Department for Molecular Biomedical Research,
Unit of Molecular Signal Transduction in Inflammation, VIB, Ghent, Belgium, 3Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium,
4Department of Cellular and Developmental biology, School of Medicine, University of Colorado Denver, Aurora, Colorado, United States of America
Abstract
During lung development, Fibroblast growth factor 10 (Fgf10), which is expressed in the distal mesenchyme and regulated
by Wnt signaling, acts on the distal epithelial progenitors to maintain them and prevent them from differentiating into
proximal (airway) epithelial cells. Fgf10-expressing cells in the distal mesenchyme are progenitors for parabronchial smooth
muscle cells (PSMCs). After naphthalene, ozone or bleomycin-induced airway epithelial injury, surviving epithelial cells
secrete Wnt7b which then activates the PSMC niche to induce Fgf10 expression. This Fgf10 secreted by the niche then acts
on a subset of Clara stem cells to break quiescence, induce proliferation and initiate epithelial repair. Here we show that
conditional deletion of the Wnt target gene c-Myc from the lung mesenchyme during development does not affect proper
epithelial or mesenchymal differentiation. However, in the adult lung we show that after naphthalene-mediated airway
epithelial injury c-Myc is important for the activation of the PSMC niche and as such induces proliferation and Fgf10
expression in PSMCs. Our data indicate that conditional deletion of c-Myc from PSMCs inhibits airway epithelial repair,
whereas c-Myc ablation from Clara cells has no effect on airway epithelial regeneration. These findings may have important
implications for understanding the misregulation of lung repair in asthma and COPD.
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Introduction
A complex interplay between endodermal and mesodermal cell
types defines early developmental competence and cell fate in the
lung. As such, proximal-distal patterning of the lung is accompa-
nied by the gradual restricted ability of developmental progenitors
to generate the various epithelial lineages in the mature organ [1].
During lung development, Fgf10 (Fibroblast growth factor 10) is
expressed in mesenchyme distal to the branching tips where it
maintains the multipotent distal epithelial progenitors, but is
suppressed proximally and at bifurcation points [2,3,4,5,6,7]. We
previously identified the Fgf10-expressing cells in the distal
mesenchyme as parabronchial smooth muscle cell (PSMC)
progenitors [3,8]. Fgf10 expression as well as the amplification of
these PSMC progenitors is regulated by Wnt signaling [3,9,10].
Suppression of Fgf10 expression around the developing airway is
crucial to allow for proper maturation of the lung airway
epithelium [11,12,13,14,15].
The adult lung is a vital and complex organ that normally turns
over very slowly. The epithelial cells that line the airways are
constantly exposed to potential toxic agents and pathogens in the
environment, and they must therefore be able to respond quickly
and effectively to both cellular damage and local production of
immune cytokines. Adult stem cells are implicated in both
homeostatic tissue maintenance and functional restoration after
injury in organs such as skin and gut.
A widely used lung injury model involves the destruction of
Clara cells by naphthalene. Only those Clara cells that express
cytochrome P4502F2 (encoded by Cyp2f2) are able to convert
naphthalene into toxic epoxides leading to cell death. Within a few
hours after naphthalene administration nearly all Clara cells have
died, except for the few less differentiated variant Clara stem cells
that do not express Cyp2f2, making them therefore resistant against
naphthalene [16,17,18,19,20]. Ciliated cells quickly spread out, or
squamate, under the dying Clara cells in an attempt to cover the
basal lamina and maintain the permeability barrier of the
epithelium [21].
We have previously shown that surviving ciliated cells after
naphthalene, ozone or bleomycin-mediated airway epithelial
injury start to secrete Wnt7b, which then activates the PSMC
niche to induce Fgf10 expression [22]. We found that Fgf10
secreted by the niche acts on surviving Clara stem cells to break
quiescence, induce proliferation and initiate epithelial repair. Here
we show that after naphthalene-mediated airway epithelial injury,
the Wnt target c-Myc is important for the activation of the PSMC
niche and as such induces proliferation and Fgf10 expression in
PSMCs. Myc proteins coordinate many interdependent processes,
including cell growth (increase in cell mass), cell proliferation
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(DNA replication and cell cycle progression), differentiation and
apoptosis [23]. Using an allelic series of mice in which c-Myc
expression was incrementally reduced to zero, Trumpp et al.
showed that fibroblasts from these mice exhibit reduced prolifer-
ation and after complete loss of c-Myc function exit the cell cycle
[24]. Our data indicate that conditional deletion of c-Myc from
PSMCs prevents activation of the airway epithelial stem cell niche
after airway epithelial injury resulting in deficient epithelial repair.
Results
c-Myc Expression in the Lung Mesenchyme is not
Required for Normal Lung Development
During lung development, Nmyc expression is normally restrict-
ed to a distal population of undifferentiated epithelial cells [25],
whereas c-Myc is only expressed in the mesenchyme [3]. c-Myc
expression is regulated by b-catenin signaling and is lost upon
conditional deletion of b-catenin from the lung mesenchyme [3]. In
some organs most of the effects of b-catenin signaling are primarily
mediated by c-Myc [26]. To test whether during lung development
the effects of mesenchymal b-catenin signaling are primarily
mediated via c-Myc we conditionally deleted c-Myc from the lung
mesenchyme using a Dermo1(Twist2)-Cre line [27]. Interestingly,
while ablation of b-catenin from the lung mesenchyme resulted in
major differentiation defects and reduced Fgf10 expression [3,28],
we found that conditional deletion of c-Myc from the lung
mesenchyme has no significant effect on either (Fig. 1A–D). At
E18.5, Dermo1-Cre;c-Mycf/f [24] conditional knock out lungs appear
normal, with normal Fgf10 expression (Fig. 1A,B) and with proper
differentiation of the airway and vascular smooth muscle cells
(Fig. 1C,D), proper differentiation of the distal epithelium in ATII
(Sftpc) and ATI (Pdpn) cells (Fig. 1C–F) and proper differentiation
of the bronchial epithelium into Clara (Scgb1a1) and ciliated cells
(ß-Tub) (Fig. 1G,H).
c-Myc Regulates Activation of the Airway Epithelial Stem
Cell Niche after Airway Epithelial Injury
We recently showed that after airway epithelial injury, surviving
epithelial cells secrete Wnt7b, which then activates PSMCs (which
constitute a niche for airway epithelial stem cells) to induce
proliferation and Fgf10 expression [22]. This Fgf10 secreted by the
PSMC niche then acts on a subset of Clara stem cells to break
quiescence, induce proliferation and initiate epithelial repair [22].
To investigate the requirement of c-Myc in the activation of the
PSMC niche and the induction of Fgf10 expression in the adult
lung after airway epithelial injury we generated Myh11-Cre;c-Mycf/f
mice (Myh11: smooth muscle myosin heavy chain) [29], in which
we conditionally deleted c-Myc from the PSMCs, shown by in situ
hybridization in Fig. 2A,B. Interestingly, we found that the PSMC
niche in Myh11-Cre;c-Mycf/f lungs does not get activated after
naphthalene-mediated airway epithelial injury. This is manifested
by reduced proliferation of the PSMCs, as 9.2% 61% of PSMCs
were BrdU positive in control lungs vs. 2.6% 60.23% of PSMCs
in Myh11-Cre;c-Mycf/f lungs (P= 0.000005, n$4) (Fig. 2C,D) [22].
To investigate whether induction of Fgf10 expression is also
regulated by c-Myc we crossed Myh11-Cre;c-Mycf/f mice with an
Fgf10LacZ reporter line [3,7,8,22,30]. In contrast to our observa-
tions during lung development we found that in the adult lung, 3
days after naphthalene-mediated airway epithelial injury, Fgf10
expression in the PSMC niche is regulated by c-Myc, as
demonstrated by the lack of induction of Fgf10 expression in
Myh11-Cre;c-Mycf/f;Fgf10LacZ mice (Fig. 2F) compared to control
littermates (Fig. 2E). We previously reported a similar drastic
reduction in Fgf10 expression and proliferation in PSMCs, after
naphthalene-mediated airway epithelial injury, in mice overex-
pressing Dkk1, a secreted inhibitor of Wnt signaling [22]. To
investigate whether epithelial Fgf10 signaling is also reduced we
checked for Scgb1a1+Sftcp+ [22,31] and Scgb1a1+Fgfr2b+ [22]
double positive Clara stem cells in the regenerating distal airways
near bronchoalveolar duct junctions (BADJs). In accordance with
our previously reported results showing that Sftpc and Fgfr2b
expression in Clara stem cells is at least in part regulated by Fgf10
[22], we found a reduction in Scgb1a1+Sftcp+ and
Scgb1a1+Fgfr2b+ double positive distal airway Clara stem cells
at the BADJs in Myh11-Cre;c-Mycf/f mice 7 days after naphthalene
injury compared to control littermates (Fig. 3A–D) [22,31,32].
Conditional Deletion of c-Myc from Airway Smooth
Muscle Severely Impairs Airway Epithelial Regeneration
After Injury
Fgf10 secreted by the PSMC niche after airway epithelial injury
is critical for proper regeneration of the airway epithelium [22].
We next investigated how airway epithelial regeneration is affected
in Myh11-Cre;c-Mycf/f mice with a conditional inactivation of c-Myc
from the PSMC niche. Myh11-Cre;c-Mycf/f and control littermates
were injured with naphthalene resulting in a .95% decrease in
Scgb1a1 expression, as a measure of Clara cell loss, by 3 days after
injury and airway epithelial regeneration was monitored over time.
At 3 days post injury both control and Myh11-Cre;c-Mycf/f mice
show similar levels of injury demonstrated by low levels of Scgb1a1
mRNA expression (a Clara stem cell-specific marker) and the
presence of limited Scgb1a1 positive Clara stem cells at BADJs
and near CGRP-expressing neuroendocrine bodies, while most of
the airway is lined with ciliated cells (b-tubulin) (Fig. 4A,D,G,J,M).
At 7 days after injury, Myh11-Cre;c-Mycf/f mice show a 40%
decrease in airway epithelial regeneration (Fig. 4H,K,M) com-
pared to control mice (Fig. 4B,E,M). This decrease in regeneration
is even more evident at 14 days post injury, with Myh11-Cre;c-
Mycf/f mice showing an almost 3 fold decrease in regeneration
(Fig. 4I,L,M) compared to control mice (Fig. 4C,F,M).
Conditional Deletion of c-Myc from Clara Stem Cells does
not Affect Airway Epithelial Regeneration after Injury
We have previously shown that after naphthalene injury a
subset of Clara cells undergo a transient epithelial to mesenchymal
transition (EMT) to acquire stem cell-like properties and as such
are able to transiently induce the expression of Myh11 [22]. To
investigate whether the decrease in airway epithelial regeneration
in Myh11-Cre;c-Mycf/f mice is not due to deletion of c-Myc from
these Clara cells, transiently expressing Myh11-Cre, we generated
Scgb1a1-Cre;c-Mycf/f [33,34] mice in which the c-Myc gene is
deleted specifically from all Clara cells. We found that airway
epithelial regeneration after naphthalene injury is not affected in
Scgb1a1-Cre;c-Mycf/f mice compared to control littermates (Fig. 5A–
E), indicating that epithelial c-Myc does not play an important role
in airway epithelial regeneration and that the defect in regener-
ation observed in Myh11-Cre;c-Mycf/f mice can be attributed solely
to the loss of c-Myc from the PSMC niche. This is consistent with
the fact that during lung development c-Myc expression is
restricted to the mesenchyme, whereas Nmyc is expressed solely
in the epithelium [3,25].
Discussion
The lung has a complex three-dimensional structure that
features major differences along its proximal-distal axis in terms of
the composition of the endoderm-derived epithelium. The trachea
and primary lung buds arise by different morphogenetic processes
c-Myc Activates the Airway Stem Cell Niche
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Figure 1. Mesenchyme-specific c-Myc ablation does not affect lung development. (A,B) Fgf10 in situ hybridization on E18.5 ctrl (A) and
Dermo1-Cre;c-Mycf/f (B) lungs showing that Fgf10 expression is not affected. (C–H) Immunostaining for a-SMA (smooth muscle cells) and Sftpc (ATII
cells) (C,D), PDPN (ATI cells) (E,F), and Scgb1a1 (Clara cells) and b-tubulin (ciliated cells) (G,H) on E18.5 ctrl (C,E,G) and Dermo1-Cre;c-Mycf/f (D,F,H)
lungs. n$3. Scale bars: 100 mM (A,B and G,H); 200 mM (C–F).
doi:10.1371/journal.pone.0071426.g001
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from contiguous regions of the embryonic foregut [35]. A
distinguishing feature of the adult mouse cartilaginous airways
(i.e. trachea and primary bronchi) is that Fgf10 is expressed in the
mesenchyme between the cartilage rings [36,37] and that they
contain a discontinuous population of basal stem cells that express
p63 and specific keratins (K14 and K5). In addition to basal cells,
the luminal epithelium in cartilaginous airways consists of two
main columnar epithelial cell types: ciliated cells and Clara cells
with a limited number of Clara cell-derived goblet cells. Ciliated
cells contain cilia which are involved in the clearance of mucus
produced by goblet cells, whereas Clara cells produce secretoglo-
bins, the most abundant of which is Scgb1a1 (also known as
CCSP, CC10 and CCA) [38,39,40].
The more distal airways (small bronchi and bronchioles) have a
columnar epithelium surrounded by airway smooth muscle which
does not express Fgf10 during normal homeostasis [8]. Clara stem
cells predominate over ciliated cells and there are more
neuroendocrine cells than in the trachea. More importantly, there
is no evidence of basal cells in smaller airways in the mouse during
normal homeostasis [41].
In the cartilaginous airways basal cells are considered to be on
top of the stem cell hierarchy and are able to self renew and give
rise to both Clara cells, goblet cells and ciliated cells [42]. Clara
Figure 2. c-Myc regulates activation of the airway epithelial stem cell niche after airway epithelial injury. (A,B) c-Myc in situ
hybridization on ctrl (A) and Myh11-cre;c-Mycf/f (B) lungs 7 days after naphthalene injury, showing that c-Myc is expressed by airway smooth muscle
cells after airway epithelial injury and the absence of c-Myc expression in Myh11-cre;c-Mycf/f lungs. (C,D) Immunostaining for BrdU (proliferation
marker) and a-SMA (airway smooth muscle cells) on ctrl (C) and Myh11-cre;c-Mycf/f (D) lungs 3 days after naphthalene treatment. (E,F) b-gal staining
on Fgf10LacZ ctrl (E) and Myh11-cre;c-Mycf/f;Fgf10LacZ (F) lungs 3 days after naphthalene injury. n$3. Scale bars: 50 mM (A,B); 100 mM (C,D); 200 mM (E,F).
doi:10.1371/journal.pone.0071426.g002
c-Myc Activates the Airway Stem Cell Niche
PLOS ONE | www.plosone.org 4 August 2013 | Volume 8 | Issue 8 | e71426
cells themselves are also considered stem cells and during normal
homeostasis can give rise to new Clara cells and terminally
differentiated ciliated cells [43,44]. Cellular plasticity (including
but not limited to differentiation, dedifferentiation, and transdif-
ferentiation) is a frequently encountered cell behavior during
injury repair [45,46,47,48,49,50,51]. Interestingly, p63 is a master
regulator required for the development of basal cells [52] and
induces a basal cell phenotype and squamous metaplasia when
ectopically expressed in Clara cells [53]. This form of Clara cell
reprogramming may happen to some extent after airway epithelial
injury, as under such conditions Clara cells have been shown to be
able to give rise to basal cells [44].
Interestingly, our unpublished data suggest that Fgf10 plays a
role in the differentiation of airway epithelial cells into basal stem
cells during lung development (Volckaert et al., manuscript
submitted).
Our data presented here indicate that c-Myc plays an important
role in regulating the activity of the PSMC niche in the adult lung.
We found a role for c-Myc in regulating proliferation of PSMCs as
well as the induction of Fgf10 expression within PSMCs cells after
airway epithelial injury. Interestingly, we found no important role
for c-Myc in the mesenchyme during lung development indicating
that the function of c-Myc during lung development is redundant
and that other not yet identified factors may compensate for the
loss of c-Myc during lung development. The lack of defective
smooth muscle cell differentiation or maintenance in Myh-Cre;c-
Mycf/f lungs suggests that c-Myc may play a specific role in
activation of the PSMC niche after injury. Together with the
finding that epithelial c-Myc does not play an important role in
lung epithelial homeostasis or repair after injury we conclude that
targeting c-Myc may be a great way to treat lung diseases
characterized by abnormal proliferation of smooth muscle cells,
such as asthma and pulmonary arterial hypertension in which Wnt
signaling plays a role [54]. In addition, we have previously shown
that Fgf10 secreted by the PSMCs modulates the differentiation of
Clara cells into goblet cells [22], which is a hallmark of the
asthmatic airway. Future experiments will be needed to determine
if loss of mesenchymal c-Myc may also reduce proliferation of
(myo)fibroblasts in the bleomycin model of pulmonary fibrosis, in
which Wnt signaling plays an important role
[55,56,57,58,59,60,61]. If so, targeting c-Myc might be an




All experiments were conducted in strict accordance with the
recommendations in the guide for the care and use of laboratory
animals. The protocol was approved by the National Jewish
Health institutional animal care and use committee #AS2774.
Mouse Strains
Myh11-Cre [Tg(Myh11-cre,-EGFP)2Mik/J] mice were obtained
from Jackson Laboratories. Dermo1-Cre mice were a kind gift from
Dr. David Ornitz [27]. Scgb1a1-Cre were a kind gift from Dr.
Thomas Mariani [33,34]. c-Mycf/f mice were a kind gift from Dr.
Andreas Trumpp [24]. Adult mice were 8 weeks old at time of
Figure 3. Conditional c-Myc deletion from PSMCs reduces Fgf10 signaling in Clara stem cells after naphthalene-mediated injury. (A–
D) Immunostaining for Scgb1a1 and Sftpc (A,B), Scgb1a1 and Fgfr2b (C,D) on ctrl (A,C) and Myh11-cre;c-Mycf/f (B,D) lungs 7 days after naphthalene.
n$3. Scale bars: 50 mM (A–D).
doi:10.1371/journal.pone.0071426.g003
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Figure 4. Conditional c-Myc deletion from the epithelial stem cell niche impairs epithelial regeneration after injury. (A–L)
Immunostaining for Scgb1a1 (Clara stem cells) and b-tubulin (ciliated cells) (A–C,G–I) or Scgb1a1 (Clara stem cells) and CGRP (neuroendocrine bodies)
(D–F,J–L) on ctrl (A–F) and Myh11-cre;c-Mycf/f (G–L) lungs 3 days (A,D,G,J), 7 days (B,E,H,K) and 14 days (C,F,I,L) after naphthalene injury. (M) qPCR
analysis of relative Scgb1a1 mRNA abundance in lungs from ctrl and Myh11-cre;c-Mycf/f mice 3, 7 and 14 days after naphthalene treatment. **P,0.01,
*P,0.05 vs. respective control. n$3. Scale bars: 200 mM (A–C and G–I); 50 mM (D–F and J–L).
doi:10.1371/journal.pone.0071426.g004
c-Myc Activates the Airway Stem Cell Niche
PLOS ONE | www.plosone.org 6 August 2013 | Volume 8 | Issue 8 | e71426
naphthalene administration. Animals were maintained in a
pathogen-free environment.
b-gal Staining
Tissues containing Fgf10LacZ allele were dissected, and b-gal
staining was performed at 3 days after naphthalene injury. Lungs
were dissected and fixed in 4% PFA in PBS at room temperature
for 5 minutes, rinsed in PBS, injected with freshly prepared X-gal
solution, transferred into a vial of X-gal solution, and stained at
37uC overnight. After rinsing with PBS, lungs were postfixed in
4% PFA in PBS at room temperature overnight. For microtome
sections, after 4% PFA fixation, lungs were washed in PBS,
dehydrated, and paraffin embedded.
Immunofluorescence
All staining was done on paraffin sections of formalin-fixed
lungs. Immunofluorescent staining was performed with the
following primary antibodies: mouse anti–b-tubulin (3F3-G2;
Seven Hills Bioreagents), goat anti-Scgb1a1 (T-18; Santa Cruz
Biotechnology Inc.), rabbit anti-Scgb1a1 (Seven Hills Bioreagents),
rabbit anti-CGRP (Sigma-Aldrich), rabbit anti-Fgfr2 (Bek) (C-17;
Santa Cruz Biotechnology Inc.), mouse anti–a-SMA cy3 conju-
gate and unconjugated (14A; Sigma-Aldrich), rabbit anti-Sftpc
(Seven Hills Bioreagents), mouse anti-PDPN (Iowa hybridoma
bank). All fluorescent staining was performed with secondary
antibodies from Jackson Immunoresearch (except the Cy3-
conjugated a-SMA) and mounted using Vectashield with DAPI
Figure 5. Epithelial c-Myc deletion does not affect airway epithelial regeneration after injury. (A–D) Immunostaining for Scgb1a1 (Clara
stem cells) and b-tubulin (ciliated cells) (A,B) or Scgb1a1 (Clara stem cells) and CGRP (neuroendocrine bodies) (C,D) on ctrl (A,C) and Scgb1a1-Cre;c-
Mycf/f (B,D) lungs 7 days after naphthalene injury. (E) qPCR analysis of relative Scgb1a1 mRNA abundance in lungs from ctrl and Scgb1a1-Cre;c-Mycf/f
mice 7 days after naphthalene treatment. P.0.05, n$3. Scale bars: 200 mM (A,B); 50 mM (C,D).
doi:10.1371/journal.pone.0071426.g005
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(Vector Labs). Photographs were taken with a Zeiss AxioImager
and Axiovision software.
qPCR
RNA was isolated from lung accessory lobes using RNALater
(Ambion) and Total RNA Kit I (Omega Biotek) according to the
manufacturer’s instructions. RNA concentration was determined
by spectrophotometry. cDNA was generated using SuperScript III
First-Strand Synthesis System (Invitrogen) according to the
manufacturer’s instructions. Comparative real-time PCR was
performed for b-glucuronidase (Mm00446953_m1) and Scgb1a1
(Mm00442046_m1) Taqman Gene Expression Assays (Applied
Biosystems) using a StepOne Plus system (Applied Biosystems). b-
glucuronidase was used as a reference control to normalize equal
loading of template cDNA.
Naphthalene Treatment
Naphthalene (Sigma-Aldrich) was dissolved in corn oil at
30 mg/ml and administered intraperitoneally at 8 weeks of age,
with doses adjusted according to strain to achieve a 95% decrease
in the abundance of Scgb1a1 mRNA in total lung RNA of WT
mice at 3 days after injection. Control mice for regeneration
studies were WT littermates.
Proliferation
Mice were given intraperitoneal injections of 10 ml BrdU (GE
Healthcare) per gram body weight 4 hours before sacrifice. Lungs
were fixed in 4% paraformaldehyde, dehydrated, and paraffin
embedded. Sections were treated with monoclonal anti-BrdU
(clone BU-1; GE Healthcare) according to the manufacturer’s
instructions. FITC-labeled anti-mouse secondary antibodies were
used (Jackson Immunoresearch). All slides were mounted using
Vectashield with DAPI.
In situ Hybridization
In situ hybridization on paraffin sections of formalin-fixed lungs
was performed as previously described [3]. A 584-bp Fgf10 mouse
cDNA [2] and 201-bp fragment of c-Myc [3] mouse cDNA were
used as templates for the synthesis of digoxigenin-labeled antisense
riboprobes.
Statistics
For BrdU labeling and qPCR analysis, each experiment was
repeated with samples obtained from at least 3 different lungs
preparations. All results are expressed as mean 6 SEM. The
significance of differences between 2 sample means was deter-
mined by the Student’s t test. P values less than 0.05 were
considered statistically significant.
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